nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS2—Lenalidomide—hematologic cancer	0.154	0.209	CbGbCtD
Bromfenac—PTGS2—Thalidomide—hematologic cancer	0.0824	0.111	CbGbCtD
Bromfenac—PTGS1—Bortezomib—hematologic cancer	0.0798	0.108	CbGbCtD
Bromfenac—PTGS1—Thalidomide—hematologic cancer	0.0696	0.0941	CbGbCtD
Bromfenac—PTGS1—Ifosfamide—hematologic cancer	0.0612	0.0828	CbGbCtD
Bromfenac—PTGS1—Imatinib—hematologic cancer	0.0585	0.0791	CbGbCtD
Bromfenac—PTGS2—Triamcinolone—hematologic cancer	0.0571	0.0772	CbGbCtD
Bromfenac—PTGS2—Betamethasone—hematologic cancer	0.049	0.0662	CbGbCtD
Bromfenac—PTGS2—Cisplatin—hematologic cancer	0.0353	0.0477	CbGbCtD
Bromfenac—PTGS2—Etoposide—hematologic cancer	0.0347	0.0469	CbGbCtD
Bromfenac—PTGS1—Etoposide—hematologic cancer	0.0293	0.0396	CbGbCtD
Bromfenac—PTGS2—Dexamethasone—hematologic cancer	0.0285	0.0385	CbGbCtD
Bromfenac—PTGS2—ovarian follicle—hematologic cancer	0.00815	0.556	CbGeAlD
Bromfenac—Visual acuity reduced—Lenalidomide—hematologic cancer	0.00133	0.00834	CcSEcCtD
Bromfenac—Swelling face—Ifosfamide—hematologic cancer	0.00129	0.00813	CcSEcCtD
Bromfenac—Ocular discomfort—Methotrexate—hematologic cancer	0.00128	0.00807	CcSEcCtD
Bromfenac—Balsalazide—ALOX5—hematologic cancer	0.00127	0.221	CrCbGaD
Bromfenac—Sensation of foreign body—Dexamethasone—hematologic cancer	0.00123	0.00772	CcSEcCtD
Bromfenac—Sensation of foreign body—Betamethasone—hematologic cancer	0.00123	0.00772	CcSEcCtD
Bromfenac—Photophobia—Pentostatin—hematologic cancer	0.00112	0.00703	CcSEcCtD
Bromfenac—Epistaxis—Ruxolitinib—hematologic cancer	0.0011	0.00693	CcSEcCtD
Bromfenac—Conjunctival hyperaemia—Prednisolone—hematologic cancer	0.00109	0.00686	CcSEcCtD
Bromfenac—Eye irritation—Nilotinib—hematologic cancer	0.00107	0.0067	CcSEcCtD
Bromfenac—Eye irritation—Imatinib—hematologic cancer	0.00106	0.00666	CcSEcCtD
Bromfenac—Visual acuity reduced—Alitretinoin—hematologic cancer	0.00105	0.00659	CcSEcCtD
Bromfenac—PTGS1—hematopoietic system—hematologic cancer	0.00103	0.0702	CbGeAlD
Bromfenac—PTGS2—hematopoietic system—hematologic cancer	0.000984	0.0671	CbGeAlD
Bromfenac—Eye pain—Daunorubicin—hematologic cancer	0.000962	0.00605	CcSEcCtD
Bromfenac—Photophobia—Procarbazine—hematologic cancer	0.000943	0.00593	CcSEcCtD
Bromfenac—Eye irritation—Lenalidomide—hematologic cancer	0.000923	0.00581	CcSEcCtD
Bromfenac—Conjunctival hyperaemia—Dexamethasone—hematologic cancer	0.000909	0.00572	CcSEcCtD
Bromfenac—Conjunctival hyperaemia—Betamethasone—hematologic cancer	0.000909	0.00572	CcSEcCtD
Bromfenac—Photophobia—Nilotinib—hematologic cancer	0.000854	0.00537	CcSEcCtD
Bromfenac—Eye irritation—Bortezomib—hematologic cancer	0.00085	0.00535	CcSEcCtD
Bromfenac—Retinal disorder—Methotrexate—hematologic cancer	0.000815	0.00513	CcSEcCtD
Bromfenac—Photophobia—Vinblastine—hematologic cancer	0.0008	0.00504	CcSEcCtD
Bromfenac—Eye pain—Bexarotene—hematologic cancer	0.000792	0.00498	CcSEcCtD
Bromfenac—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000788	0.209	CbGdCrCtD
Bromfenac—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000788	0.209	CbGdCrCtD
Bromfenac—Suprofen—UGT1A1—hematologic cancer	0.000775	0.135	CrCbGaD
Bromfenac—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.00077	0.205	CbGdCrCtD
Bromfenac—Stinging—Alitretinoin—hematologic cancer	0.000768	0.00483	CcSEcCtD
Bromfenac—Asthma—Pentostatin—hematologic cancer	0.000747	0.0047	CcSEcCtD
Bromfenac—Asthma—Anagrelide—hematologic cancer	0.000747	0.0047	CcSEcCtD
Bromfenac—Eye pain—Nilotinib—hematologic cancer	0.000731	0.0046	CcSEcCtD
Bromfenac—Eye irritation—Alitretinoin—hematologic cancer	0.000729	0.00459	CcSEcCtD
Bromfenac—Eye pain—Imatinib—hematologic cancer	0.000727	0.00458	CcSEcCtD
Bromfenac—Eye irritation—Ifosfamide—hematologic cancer	0.000721	0.00453	CcSEcCtD
Bromfenac—PTGS1—blood—hematologic cancer	0.000682	0.0465	CbGeAlD
Bromfenac—Photophobia—Bortezomib—hematologic cancer	0.000681	0.00429	CcSEcCtD
Bromfenac—Epistaxis—Nelarabine—hematologic cancer	0.000674	0.00424	CcSEcCtD
Bromfenac—Cough—Vorinostat—hematologic cancer	0.000673	0.00423	CcSEcCtD
Bromfenac—Visual acuity reduced—Dexamethasone—hematologic cancer	0.000672	0.00423	CcSEcCtD
Bromfenac—Visual acuity reduced—Betamethasone—hematologic cancer	0.000672	0.00423	CcSEcCtD
Bromfenac—PTGS2—blood—hematologic cancer	0.000652	0.0445	CbGeAlD
Bromfenac—Asthma—Busulfan—hematologic cancer	0.00065	0.00409	CcSEcCtD
Bromfenac—Photophobia—Thiotepa—hematologic cancer	0.000635	0.004	CcSEcCtD
Bromfenac—Epistaxis—Clofarabine—hematologic cancer	0.000631	0.00397	CcSEcCtD
Bromfenac—PTGS2—bone marrow—hematologic cancer	0.000631	0.043	CbGeAlD
Bromfenac—Epistaxis—Anagrelide—hematologic cancer	0.000628	0.00395	CcSEcCtD
Bromfenac—Asthma—Dasatinib—hematologic cancer	0.000618	0.00389	CcSEcCtD
Bromfenac—Eye disorder—Nelarabine—hematologic cancer	0.0006	0.00377	CcSEcCtD
Bromfenac—PTGS1—lung—hematologic cancer	0.000598	0.0408	CbGeAlD
Bromfenac—Tolmetin—MPO—hematologic cancer	0.000594	0.103	CrCbGaD
Bromfenac—Stinging—Prednisolone—hematologic cancer	0.000592	0.00372	CcSEcCtD
Bromfenac—Photophobia—Alitretinoin—hematologic cancer	0.000585	0.00368	CcSEcCtD
Bromfenac—Eye pain—Bortezomib—hematologic cancer	0.000583	0.00367	CcSEcCtD
Bromfenac—Mediastinal disorder—Nelarabine—hematologic cancer	0.000578	0.00364	CcSEcCtD
Bromfenac—PTGS2—lung—hematologic cancer	0.000572	0.039	CbGeAlD
Bromfenac—Indomethacin—ABCC3—hematologic cancer	0.000571	0.099	CrCbGaD
Bromfenac—PTGS1—testis—hematologic cancer	0.000564	0.0385	CbGeAlD
Bromfenac—Eye irritation—Prednisolone—hematologic cancer	0.000561	0.00353	CcSEcCtD
Bromfenac—Eye disorder—Anagrelide—hematologic cancer	0.000559	0.00352	CcSEcCtD
Bromfenac—Epistaxis—Busulfan—hematologic cancer	0.000546	0.00344	CcSEcCtD
Bromfenac—Stinging—Triamcinolone—hematologic cancer	0.000544	0.00342	CcSEcCtD
Bromfenac—Mediastinal disorder—Clofarabine—hematologic cancer	0.000541	0.00341	CcSEcCtD
Bromfenac—Mediastinal disorder—Anagrelide—hematologic cancer	0.000539	0.00339	CcSEcCtD
Bromfenac—Epistaxis—Procarbazine—hematologic cancer	0.00053	0.00333	CcSEcCtD
Bromfenac—Vision blurred—Nelarabine—hematologic cancer	0.000527	0.00331	CcSEcCtD
Bromfenac—Eye pain—Thalidomide—hematologic cancer	0.000526	0.00331	CcSEcCtD
Bromfenac—Epistaxis—Dasatinib—hematologic cancer	0.00052	0.00327	CcSEcCtD
Bromfenac—Epistaxis—Bexarotene—hematologic cancer	0.00052	0.00327	CcSEcCtD
Bromfenac—Epistaxis—Fludarabine—hematologic cancer	0.000518	0.00326	CcSEcCtD
Bromfenac—Diclofenac—ALOX5—hematologic cancer	0.000507	0.088	CrCbGaD
Bromfenac—Eye pain—Carmustine—hematologic cancer	0.000505	0.00318	CcSEcCtD
Bromfenac—Asthma—Lenalidomide—hematologic cancer	0.000495	0.00311	CcSEcCtD
Bromfenac—Stinging—Betamethasone—hematologic cancer	0.000494	0.00311	CcSEcCtD
Bromfenac—Stinging—Dexamethasone—hematologic cancer	0.000494	0.00311	CcSEcCtD
Bromfenac—Indomethacin—UGT1A1—hematologic cancer	0.000493	0.0856	CrCbGaD
Bromfenac—Vision blurred—Anagrelide—hematologic cancer	0.000491	0.00309	CcSEcCtD
Bromfenac—Cough—Nelarabine—hematologic cancer	0.000488	0.00307	CcSEcCtD
Bromfenac—Eye disorder—Busulfan—hematologic cancer	0.000486	0.00306	CcSEcCtD
Bromfenac—Epistaxis—Nilotinib—hematologic cancer	0.00048	0.00302	CcSEcCtD
Bromfenac—Epistaxis—Imatinib—hematologic cancer	0.000477	0.003	CcSEcCtD
Bromfenac—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000476	0.126	CbGdCrCtD
Bromfenac—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000476	0.126	CbGdCrCtD
Bromfenac—Epistaxis—Cladribine—hematologic cancer	0.000469	0.00295	CcSEcCtD
Bromfenac—Mediastinal disorder—Busulfan—hematologic cancer	0.000469	0.00295	CcSEcCtD
Bromfenac—Headache—Ruxolitinib—hematologic cancer	0.000467	0.00294	CcSEcCtD
Bromfenac—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000465	0.124	CbGdCrCtD
Bromfenac—Eye disorder—Bexarotene—hematologic cancer	0.000462	0.00291	CcSEcCtD
Bromfenac—Eye disorder—Dasatinib—hematologic cancer	0.000462	0.00291	CcSEcCtD
Bromfenac—Cough—Daunorubicin—hematologic cancer	0.000456	0.00287	CcSEcCtD
Bromfenac—Cough—Clofarabine—hematologic cancer	0.000456	0.00287	CcSEcCtD
Bromfenac—Cough—Anagrelide—hematologic cancer	0.000454	0.00286	CcSEcCtD
Bromfenac—Cough—Pentostatin—hematologic cancer	0.000454	0.00286	CcSEcCtD
Bromfenac—Mediastinal disorder—Dasatinib—hematologic cancer	0.000446	0.0028	CcSEcCtD
Bromfenac—Diclofenac—UGT1A1—hematologic cancer	0.000445	0.0773	CrCbGaD
Bromfenac—Aminohippurate—SLC22A1—hematologic cancer	0.000432	0.075	CrCbGaD
Bromfenac—Eye disorder—Nilotinib—hematologic cancer	0.000427	0.00269	CcSEcCtD
Bromfenac—Eye disorder—Imatinib—hematologic cancer	0.000425	0.00267	CcSEcCtD
Bromfenac—Eye disorder—Cladribine—hematologic cancer	0.000417	0.00262	CcSEcCtD
Bromfenac—Epistaxis—Lenalidomide—hematologic cancer	0.000416	0.00262	CcSEcCtD
Bromfenac—Mediastinal disorder—Nilotinib—hematologic cancer	0.000412	0.00259	CcSEcCtD
Bromfenac—Mediastinal disorder—Imatinib—hematologic cancer	0.000409	0.00258	CcSEcCtD
Bromfenac—PTGS1—lymph node—hematologic cancer	0.000409	0.0279	CbGeAlD
Bromfenac—Vision blurred—Dasatinib—hematologic cancer	0.000406	0.00255	CcSEcCtD
Bromfenac—Mediastinal disorder—Cladribine—hematologic cancer	0.000402	0.00253	CcSEcCtD
Bromfenac—Cough—Busulfan—hematologic cancer	0.000395	0.00248	CcSEcCtD
Bromfenac—Headache—Vorinostat—hematologic cancer	0.000394	0.00248	CcSEcCtD
Bromfenac—PTGS2—lymph node—hematologic cancer	0.000391	0.0267	CbGeAlD
Bromfenac—Asthma—Alitretinoin—hematologic cancer	0.000391	0.00246	CcSEcCtD
Bromfenac—Pain—Nelarabine—hematologic cancer	0.00039	0.00245	CcSEcCtD
Bromfenac—Cough—Procarbazine—hematologic cancer	0.000383	0.00241	CcSEcCtD
Bromfenac—Epistaxis—Bortezomib—hematologic cancer	0.000383	0.00241	CcSEcCtD
Bromfenac—Cough—Bexarotene—hematologic cancer	0.000376	0.00236	CcSEcCtD
Bromfenac—Cough—Dasatinib—hematologic cancer	0.000376	0.00236	CcSEcCtD
Bromfenac—Vision blurred—Nilotinib—hematologic cancer	0.000375	0.00236	CcSEcCtD
Bromfenac—Cough—Fludarabine—hematologic cancer	0.000375	0.00236	CcSEcCtD
Bromfenac—Vision blurred—Imatinib—hematologic cancer	0.000373	0.00234	CcSEcCtD
Bromfenac—Eye disorder—Lenalidomide—hematologic cancer	0.00037	0.00233	CcSEcCtD
Bromfenac—Mediastinal disorder—Melphalan—hematologic cancer	0.000367	0.00231	CcSEcCtD
Bromfenac—Pain—Clofarabine—hematologic cancer	0.000365	0.0023	CcSEcCtD
Bromfenac—Pain—Daunorubicin—hematologic cancer	0.000365	0.0023	CcSEcCtD
Bromfenac—Pain—Pentostatin—hematologic cancer	0.000363	0.00229	CcSEcCtD
Bromfenac—Pain—Anagrelide—hematologic cancer	0.000363	0.00229	CcSEcCtD
Bromfenac—Epistaxis—Thiotepa—hematologic cancer	0.000357	0.00225	CcSEcCtD
Bromfenac—Mediastinal disorder—Lenalidomide—hematologic cancer	0.000357	0.00224	CcSEcCtD
Bromfenac—Cough—Nilotinib—hematologic cancer	0.000347	0.00218	CcSEcCtD
Bromfenac—Epistaxis—Thalidomide—hematologic cancer	0.000345	0.00217	CcSEcCtD
Bromfenac—Cough—Imatinib—hematologic cancer	0.000345	0.00217	CcSEcCtD
Bromfenac—Eye disorder—Bortezomib—hematologic cancer	0.00034	0.00214	CcSEcCtD
Bromfenac—Cough—Cladribine—hematologic cancer	0.000339	0.00213	CcSEcCtD
Bromfenac—Stinging—Epirubicin—hematologic cancer	0.000336	0.00212	CcSEcCtD
Bromfenac—Epistaxis—Alitretinoin—hematologic cancer	0.000328	0.00207	CcSEcCtD
Bromfenac—Mediastinal disorder—Bortezomib—hematologic cancer	0.000328	0.00207	CcSEcCtD
Bromfenac—Vision blurred—Lenalidomide—hematologic cancer	0.000325	0.00204	CcSEcCtD
Bromfenac—Eye pain—Dexamethasone—hematologic cancer	0.000322	0.00202	CcSEcCtD
Bromfenac—Eye pain—Betamethasone—hematologic cancer	0.000322	0.00202	CcSEcCtD
Bromfenac—Mediastinal disorder—Vinorelbine—hematologic cancer	0.000321	0.00202	CcSEcCtD
Bromfenac—Eye disorder—Thiotepa—hematologic cancer	0.000317	0.002	CcSEcCtD
Bromfenac—Pain—Busulfan—hematologic cancer	0.000316	0.00199	CcSEcCtD
Bromfenac—Stinging—Doxorubicin—hematologic cancer	0.000311	0.00196	CcSEcCtD
Bromfenac—Cough—Melphalan—hematologic cancer	0.000309	0.00195	CcSEcCtD
Bromfenac—Eye disorder—Thalidomide—hematologic cancer	0.000307	0.00193	CcSEcCtD
Bromfenac—Pain—Procarbazine—hematologic cancer	0.000306	0.00193	CcSEcCtD
Bromfenac—Mediastinal disorder—Thiotepa—hematologic cancer	0.000306	0.00193	CcSEcCtD
Bromfenac—Cough—Lenalidomide—hematologic cancer	0.000301	0.00189	CcSEcCtD
Bromfenac—Pain—Bexarotene—hematologic cancer	0.0003	0.00189	CcSEcCtD
Bromfenac—Pain—Dasatinib—hematologic cancer	0.0003	0.00189	CcSEcCtD
Bromfenac—Pain—Fludarabine—hematologic cancer	0.0003	0.00188	CcSEcCtD
Bromfenac—Vision blurred—Bortezomib—hematologic cancer	0.000299	0.00188	CcSEcCtD
Bromfenac—Mediastinal disorder—Thalidomide—hematologic cancer	0.000296	0.00186	CcSEcCtD
Bromfenac—Eye disorder—Carmustine—hematologic cancer	0.000295	0.00186	CcSEcCtD
Bromfenac—Eye disorder—Alitretinoin—hematologic cancer	0.000292	0.00184	CcSEcCtD
Bromfenac—Eye disorder—Ifosfamide—hematologic cancer	0.000289	0.00182	CcSEcCtD
Bromfenac—Headache—Nelarabine—hematologic cancer	0.000286	0.0018	CcSEcCtD
Bromfenac—Pain—Chlorambucil—hematologic cancer	0.000284	0.00179	CcSEcCtD
Bromfenac—Headache—Methoxsalen—hematologic cancer	0.000279	0.00176	CcSEcCtD
Bromfenac—Vision blurred—Thiotepa—hematologic cancer	0.000279	0.00175	CcSEcCtD
Bromfenac—Mediastinal disorder—Ifosfamide—hematologic cancer	0.000278	0.00175	CcSEcCtD
Bromfenac—Pain—Nilotinib—hematologic cancer	0.000278	0.00175	CcSEcCtD
Bromfenac—Cough—Bortezomib—hematologic cancer	0.000277	0.00174	CcSEcCtD
Bromfenac—Asthma—Triamcinolone—hematologic cancer	0.000277	0.00174	CcSEcCtD
Bromfenac—Pain—Imatinib—hematologic cancer	0.000276	0.00174	CcSEcCtD
Bromfenac—Cough—Bleomycin—hematologic cancer	0.000275	0.00173	CcSEcCtD
Bromfenac—Mediastinal disorder—Vincristine—hematologic cancer	0.000272	0.00171	CcSEcCtD
Bromfenac—Pain—Cladribine—hematologic cancer	0.000271	0.00171	CcSEcCtD
Bromfenac—Cough—Vinorelbine—hematologic cancer	0.00027	0.0017	CcSEcCtD
Bromfenac—Vision blurred—Thalidomide—hematologic cancer	0.00027	0.0017	CcSEcCtD
Bromfenac—Headache—Clofarabine—hematologic cancer	0.000267	0.00168	CcSEcCtD
Bromfenac—Headache—Daunorubicin—hematologic cancer	0.000267	0.00168	CcSEcCtD
Bromfenac—Headache—Pentostatin—hematologic cancer	0.000266	0.00167	CcSEcCtD
Bromfenac—Headache—Anagrelide—hematologic cancer	0.000266	0.00167	CcSEcCtD
Bromfenac—Mediastinal disorder—Irinotecan—hematologic cancer	0.000264	0.00166	CcSEcCtD
Bromfenac—Pain—Vinblastine—hematologic cancer	0.00026	0.00164	CcSEcCtD
Bromfenac—Vision blurred—Carmustine—hematologic cancer	0.000259	0.00163	CcSEcCtD
Bromfenac—Cough—Thiotepa—hematologic cancer	0.000258	0.00162	CcSEcCtD
Bromfenac—Mediastinal disorder—Gemcitabine—hematologic cancer	0.000258	0.00162	CcSEcCtD
Bromfenac—Headache—Idarubicin—hematologic cancer	0.000257	0.00162	CcSEcCtD
Bromfenac—Vision blurred—Alitretinoin—hematologic cancer	0.000256	0.00161	CcSEcCtD
Bromfenac—Vision blurred—Ifosfamide—hematologic cancer	0.000253	0.00159	CcSEcCtD
Bromfenac—Headache—Teniposide—hematologic cancer	0.00025	0.00157	CcSEcCtD
Bromfenac—Cough—Thalidomide—hematologic cancer	0.00025	0.00157	CcSEcCtD
Bromfenac—Eye disorder—Cisplatin—hematologic cancer	0.000249	0.00157	CcSEcCtD
Bromfenac—Pain—Melphalan—hematologic cancer	0.000247	0.00156	CcSEcCtD
Bromfenac—Vision blurred—Mitoxantrone—hematologic cancer	0.000241	0.00151	CcSEcCtD
Bromfenac—Pain—Lenalidomide—hematologic cancer	0.000241	0.00151	CcSEcCtD
Bromfenac—Mediastinal disorder—Cisplatin—hematologic cancer	0.00024	0.00151	CcSEcCtD
Bromfenac—Cough—Alitretinoin—hematologic cancer	0.000237	0.00149	CcSEcCtD
Bromfenac—Pain—Hydroxyurea—hematologic cancer	0.000237	0.00149	CcSEcCtD
Bromfenac—Cough—Ifosfamide—hematologic cancer	0.000235	0.00148	CcSEcCtD
Bromfenac—Epistaxis—Triamcinolone—hematologic cancer	0.000233	0.00146	CcSEcCtD
Bromfenac—Headache—Busulfan—hematologic cancer	0.000231	0.00146	CcSEcCtD
Bromfenac—Eye disorder—Etoposide—hematologic cancer	0.000228	0.00143	CcSEcCtD
Bromfenac—Headache—Procarbazine—hematologic cancer	0.000225	0.00141	CcSEcCtD
Bromfenac—Cough—Mitoxantrone—hematologic cancer	0.000223	0.0014	CcSEcCtD
Bromfenac—Cough—Irinotecan—hematologic cancer	0.000223	0.0014	CcSEcCtD
Bromfenac—Pain—Bortezomib—hematologic cancer	0.000221	0.00139	CcSEcCtD
Bromfenac—Headache—Dasatinib—hematologic cancer	0.00022	0.00138	CcSEcCtD
Bromfenac—Headache—Bexarotene—hematologic cancer	0.00022	0.00138	CcSEcCtD
Bromfenac—Mediastinal disorder—Etoposide—hematologic cancer	0.00022	0.00138	CcSEcCtD
Bromfenac—Pain—Bleomycin—hematologic cancer	0.00022	0.00138	CcSEcCtD
Bromfenac—Headache—Fludarabine—hematologic cancer	0.000219	0.00138	CcSEcCtD
Bromfenac—Eye pain—Epirubicin—hematologic cancer	0.000219	0.00138	CcSEcCtD
Bromfenac—Vision blurred—Cisplatin—hematologic cancer	0.000219	0.00137	CcSEcCtD
Bromfenac—Cough—Gemcitabine—hematologic cancer	0.000217	0.00137	CcSEcCtD
Bromfenac—Pain—Vinorelbine—hematologic cancer	0.000216	0.00136	CcSEcCtD
Bromfenac—Pain—Thiotepa—hematologic cancer	0.000206	0.0013	CcSEcCtD
Bromfenac—Headache—Nilotinib—hematologic cancer	0.000203	0.00128	CcSEcCtD
Bromfenac—Eye pain—Doxorubicin—hematologic cancer	0.000203	0.00128	CcSEcCtD
Bromfenac—Headache—Imatinib—hematologic cancer	0.000202	0.00127	CcSEcCtD
Bromfenac—Pain—Thalidomide—hematologic cancer	0.0002	0.00126	CcSEcCtD
Bromfenac—Headache—Cladribine—hematologic cancer	0.000199	0.00125	CcSEcCtD
Bromfenac—Vision blurred—Prednisolone—hematologic cancer	0.000197	0.00124	CcSEcCtD
Bromfenac—Pain—Carmustine—hematologic cancer	0.000192	0.00121	CcSEcCtD
Bromfenac—Headache—Vinblastine—hematologic cancer	0.000191	0.0012	CcSEcCtD
Bromfenac—Pain—Alitretinoin—hematologic cancer	0.00019	0.0012	CcSEcCtD
Bromfenac—Pain—Ifosfamide—hematologic cancer	0.000188	0.00118	CcSEcCtD
Bromfenac—Eye disorder—Dexamethasone—hematologic cancer	0.000188	0.00118	CcSEcCtD
Bromfenac—Eye disorder—Betamethasone—hematologic cancer	0.000188	0.00118	CcSEcCtD
Bromfenac—Cough—Etoposide—hematologic cancer	0.000185	0.00117	CcSEcCtD
Bromfenac—Pain—Vincristine—hematologic cancer	0.000183	0.00115	CcSEcCtD
Bromfenac—Asthma—Methotrexate—hematologic cancer	0.000183	0.00115	CcSEcCtD
Bromfenac—Pain—Mitoxantrone—hematologic cancer	0.000178	0.00112	CcSEcCtD
Bromfenac—Pain—Irinotecan—hematologic cancer	0.000178	0.00112	CcSEcCtD
Bromfenac—Headache—Lenalidomide—hematologic cancer	0.000176	0.00111	CcSEcCtD
Bromfenac—Headache—Hydroxyurea—hematologic cancer	0.000174	0.00109	CcSEcCtD
Bromfenac—Pain—Gemcitabine—hematologic cancer	0.000174	0.00109	CcSEcCtD
Bromfenac—Asthma—Epirubicin—hematologic cancer	0.000171	0.00108	CcSEcCtD
Bromfenac—Cough—Triamcinolone—hematologic cancer	0.000168	0.00106	CcSEcCtD
Bromfenac—Eye disorder—Prednisone—hematologic cancer	0.000163	0.00103	CcSEcCtD
Bromfenac—Headache—Bortezomib—hematologic cancer	0.000162	0.00102	CcSEcCtD
Bromfenac—Pain—Cisplatin—hematologic cancer	0.000162	0.00102	CcSEcCtD
Bromfenac—Headache—Vinorelbine—hematologic cancer	0.000158	0.000996	CcSEcCtD
Bromfenac—Asthma—Doxorubicin—hematologic cancer	0.000158	0.000995	CcSEcCtD
Bromfenac—Epistaxis—Methotrexate—hematologic cancer	0.000154	0.000966	CcSEcCtD
Bromfenac—Headache—Thiotepa—hematologic cancer	0.000151	0.000951	CcSEcCtD
Bromfenac—Pain—Etoposide—hematologic cancer	0.000148	0.000933	CcSEcCtD
Bromfenac—Headache—Thalidomide—hematologic cancer	0.000146	0.00092	CcSEcCtD
Bromfenac—Pain—Prednisolone—hematologic cancer	0.000146	0.00092	CcSEcCtD
Bromfenac—Epistaxis—Epirubicin—hematologic cancer	0.000144	0.000904	CcSEcCtD
Bromfenac—Vision blurred—Prednisone—hematologic cancer	0.000143	0.000903	CcSEcCtD
Bromfenac—Headache—Carmustine—hematologic cancer	0.00014	0.000884	CcSEcCtD
Bromfenac—Headache—Alitretinoin—hematologic cancer	0.000139	0.000875	CcSEcCtD
Bromfenac—Eye disorder—Methotrexate—hematologic cancer	0.000137	0.000859	CcSEcCtD
Bromfenac—Pain—Triamcinolone—hematologic cancer	0.000134	0.000846	CcSEcCtD
Bromfenac—Headache—Vincristine—hematologic cancer	0.000134	0.000844	CcSEcCtD
Bromfenac—Epistaxis—Doxorubicin—hematologic cancer	0.000133	0.000837	CcSEcCtD
Bromfenac—Mediastinal disorder—Methotrexate—hematologic cancer	0.000132	0.000829	CcSEcCtD
Bromfenac—Headache—Irinotecan—hematologic cancer	0.000131	0.000822	CcSEcCtD
Bromfenac—Headache—Mitoxantrone—hematologic cancer	0.000131	0.000822	CcSEcCtD
Bromfenac—Eye disorder—Epirubicin—hematologic cancer	0.000128	0.000804	CcSEcCtD
Bromfenac—Headache—Gemcitabine—hematologic cancer	0.000127	0.0008	CcSEcCtD
Bromfenac—Aminohippurate—ABCB1—hematologic cancer	0.000126	0.0218	CrCbGaD
Bromfenac—Mediastinal disorder—Epirubicin—hematologic cancer	0.000123	0.000776	CcSEcCtD
Bromfenac—Pain—Betamethasone—hematologic cancer	0.000122	0.000768	CcSEcCtD
Bromfenac—Pain—Dexamethasone—hematologic cancer	0.000122	0.000768	CcSEcCtD
Bromfenac—Indomethacin—ALB—hematologic cancer	0.000121	0.021	CrCbGaD
Bromfenac—Vision blurred—Methotrexate—hematologic cancer	0.00012	0.000754	CcSEcCtD
Bromfenac—Eye disorder—Doxorubicin—hematologic cancer	0.000118	0.000744	CcSEcCtD
Bromfenac—Indomethacin—ABCB1—hematologic cancer	0.000115	0.02	CrCbGaD
Bromfenac—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000114	0.000718	CcSEcCtD
Bromfenac—Vision blurred—Epirubicin—hematologic cancer	0.000112	0.000706	CcSEcCtD
Bromfenac—Cough—Methotrexate—hematologic cancer	0.000111	0.000699	CcSEcCtD
Bromfenac—Diclofenac—ALB—hematologic cancer	0.000109	0.0189	CrCbGaD
Bromfenac—Headache—Etoposide—hematologic cancer	0.000109	0.000683	CcSEcCtD
Bromfenac—Headache—Prednisolone—hematologic cancer	0.000107	0.000674	CcSEcCtD
Bromfenac—Diclofenac—ABCB1—hematologic cancer	0.000104	0.0181	CrCbGaD
Bromfenac—Cough—Epirubicin—hematologic cancer	0.000104	0.000654	CcSEcCtD
Bromfenac—Vision blurred—Doxorubicin—hematologic cancer	0.000104	0.000653	CcSEcCtD
Bromfenac—Headache—Triamcinolone—hematologic cancer	9.85e-05	0.00062	CcSEcCtD
Bromfenac—Ketoprofen—ALB—hematologic cancer	9.67e-05	0.0168	CrCbGaD
Bromfenac—Cough—Doxorubicin—hematologic cancer	9.61e-05	0.000605	CcSEcCtD
Bromfenac—Headache—Betamethasone—hematologic cancer	8.94e-05	0.000562	CcSEcCtD
Bromfenac—Headache—Dexamethasone—hematologic cancer	8.94e-05	0.000562	CcSEcCtD
Bromfenac—Pain—Methotrexate—hematologic cancer	8.88e-05	0.000559	CcSEcCtD
Bromfenac—Pain—Epirubicin—hematologic cancer	8.31e-05	0.000523	CcSEcCtD
Bromfenac—Headache—Prednisone—hematologic cancer	7.78e-05	0.00049	CcSEcCtD
Bromfenac—Pain—Doxorubicin—hematologic cancer	7.69e-05	0.000484	CcSEcCtD
Bromfenac—Headache—Methotrexate—hematologic cancer	6.51e-05	0.000409	CcSEcCtD
Bromfenac—Headache—Epirubicin—hematologic cancer	6.09e-05	0.000383	CcSEcCtD
Bromfenac—Headache—Doxorubicin—hematologic cancer	5.63e-05	0.000354	CcSEcCtD
Bromfenac—PTGS2—Disease—PC—hematologic cancer	5.22e-05	0.000674	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PSIP1—hematologic cancer	5.22e-05	0.000674	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IL6—hematologic cancer	5.2e-05	0.000671	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	5.12e-05	0.000661	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—TNF—hematologic cancer	5.11e-05	0.00066	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	5.11e-05	0.000659	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HDAC10—hematologic cancer	5.04e-05	0.000651	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SLC35B2—hematologic cancer	5.04e-05	0.000651	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	5e-05	0.000645	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	4.98e-05	0.000642	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—HDC—hematologic cancer	4.97e-05	0.000641	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—MTAP—hematologic cancer	4.87e-05	0.000628	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	4.75e-05	0.000613	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.63e-05	0.000598	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CDA—hematologic cancer	4.54e-05	0.000586	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	4.52e-05	0.000583	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—HRAS—hematologic cancer	4.48e-05	0.000578	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MAPK3—hematologic cancer	4.46e-05	0.000576	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PC—hematologic cancer	4.37e-05	0.000564	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MYC—hematologic cancer	4.34e-05	0.00056	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—FHL2—hematologic cancer	4.34e-05	0.00056	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TGFB1—hematologic cancer	4.33e-05	0.000559	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	4.29e-05	0.000554	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—AGRN—hematologic cancer	4.25e-05	0.000549	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	4.23e-05	0.000546	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC35B2—hematologic cancer	4.22e-05	0.000545	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GBA—hematologic cancer	4.22e-05	0.000545	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IL6—hematologic cancer	4.13e-05	0.000533	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TNF—hematologic cancer	4.04e-05	0.000522	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—HMMR—hematologic cancer	4.03e-05	0.00052	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—IDH2—hematologic cancer	4.03e-05	0.00052	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SNCA—hematologic cancer	4.03e-05	0.00052	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RPLP1—hematologic cancer	4.03e-05	0.00052	CbGpPWpGaD
Bromfenac—PTGS2—Disease—AGRN—hematologic cancer	4.03e-05	0.00052	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LEF1—hematologic cancer	3.89e-05	0.000502	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—MTAP—hematologic cancer	3.86e-05	0.000499	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.86e-05	0.000498	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HMMR—hematologic cancer	3.82e-05	0.000493	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.8e-05	0.000491	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ARNTL—hematologic cancer	3.79e-05	0.000489	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.78e-05	0.000488	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CA9—hematologic cancer	3.69e-05	0.000476	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ACP5—hematologic cancer	3.69e-05	0.000476	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.68e-05	0.000475	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.67e-05	0.000474	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NCOR2—hematologic cancer	3.64e-05	0.00047	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ELL—hematologic cancer	3.59e-05	0.000464	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	3.57e-05	0.00046	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.56e-05	0.00046	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.55e-05	0.000459	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ACP5—hematologic cancer	3.5e-05	0.000451	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.48e-05	0.000449	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—IDH1—hematologic cancer	3.47e-05	0.000448	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NCOR2—hematologic cancer	3.45e-05	0.000445	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—FHL2—hematologic cancer	3.44e-05	0.000444	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—TXN—hematologic cancer	3.43e-05	0.000443	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ABCC3—hematologic cancer	3.43e-05	0.000443	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTO1—hematologic cancer	3.43e-05	0.000443	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.39e-05	0.000437	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—AGRN—hematologic cancer	3.38e-05	0.000436	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SPHK1—hematologic cancer	3.36e-05	0.000433	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.3e-05	0.000425	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IDH1—hematologic cancer	3.29e-05	0.000424	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	3.26e-05	0.000421	CbGpPWpGaD
Bromfenac—PTGS2—Disease—GSTO1—hematologic cancer	3.25e-05	0.000419	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—UGT1A1—hematologic cancer	3.22e-05	0.000416	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.21e-05	0.000414	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—HMMR—hematologic cancer	3.2e-05	0.000413	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—IDH2—hematologic cancer	3.2e-05	0.000413	CbGpPWpGaD
Bromfenac—PTGS2—Disease—AGO2—hematologic cancer	3.18e-05	0.000411	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HDAC9—hematologic cancer	3.15e-05	0.000406	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CRABP1—hematologic cancer	3.14e-05	0.000405	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC22A1—hematologic cancer	3.14e-05	0.000405	CbGpPWpGaD
Bromfenac—PTGS2—Disease—H3F3B—hematologic cancer	3.12e-05	0.000402	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ALOX5—hematologic cancer	3.06e-05	0.000394	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.04e-05	0.000392	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.02e-05	0.00039	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ARNTL—hematologic cancer	3.01e-05	0.000388	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NPM1—hematologic cancer	3e-05	0.000387	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NUP98—hematologic cancer	2.96e-05	0.000382	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.95e-05	0.000381	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.95e-05	0.00038	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CA9—hematologic cancer	2.93e-05	0.000378	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ACP5—hematologic cancer	2.93e-05	0.000378	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NCOR2—hematologic cancer	2.89e-05	0.000373	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ADCY7—hematologic cancer	2.87e-05	0.000371	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NCOA3—hematologic cancer	2.87e-05	0.000371	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGF19—hematologic cancer	2.87e-05	0.000371	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NUP214—hematologic cancer	2.85e-05	0.000368	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RPS14—hematologic cancer	2.85e-05	0.000368	CbGpPWpGaD
Bromfenac—PTGS2—Disease—DKK1—hematologic cancer	2.83e-05	0.000365	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.82e-05	0.000364	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NUP98—hematologic cancer	2.81e-05	0.000362	CbGpPWpGaD
Bromfenac—PTGS2—Disease—STAT5B—hematologic cancer	2.81e-05	0.000362	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ABCG2—hematologic cancer	2.79e-05	0.000361	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—MTR—hematologic cancer	2.79e-05	0.000361	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—IDH1—hematologic cancer	2.75e-05	0.000355	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.75e-05	0.000355	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CST3—hematologic cancer	2.74e-05	0.000354	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ENO2—hematologic cancer	2.74e-05	0.000354	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.73e-05	0.000352	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ADCY7—hematologic cancer	2.72e-05	0.000352	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ABCC3—hematologic cancer	2.72e-05	0.000351	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTO1—hematologic cancer	2.72e-05	0.000351	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—TXN—hematologic cancer	2.72e-05	0.000351	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NUP214—hematologic cancer	2.7e-05	0.000349	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SPHK1—hematologic cancer	2.66e-05	0.000344	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTT1—hematologic cancer	2.66e-05	0.000343	CbGpPWpGaD
Bromfenac—PTGS2—Disease—XIAP—hematologic cancer	2.65e-05	0.000342	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MTR—hematologic cancer	2.65e-05	0.000342	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.62e-05	0.000338	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SDC1—hematologic cancer	2.6e-05	0.000335	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ENO2—hematologic cancer	2.6e-05	0.000335	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SMARCA4—hematologic cancer	2.58e-05	0.000333	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.56e-05	0.00033	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.51e-05	0.000324	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CRABP1—hematologic cancer	2.49e-05	0.000321	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.49e-05	0.000321	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.48e-05	0.00032	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SDC1—hematologic cancer	2.46e-05	0.000318	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.45e-05	0.000316	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ALOX5—hematologic cancer	2.43e-05	0.000313	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.43e-05	0.000313	CbGpPWpGaD
Bromfenac—PTGS2—Disease—LCK—hematologic cancer	2.39e-05	0.000308	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NUP98—hematologic cancer	2.35e-05	0.000303	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.34e-05	0.000303	CbGpPWpGaD
Bromfenac—PTGS2—Disease—H3F3A—hematologic cancer	2.34e-05	0.000302	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ADCY7—hematologic cancer	2.28e-05	0.000294	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NCOA3—hematologic cancer	2.28e-05	0.000294	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PRKCZ—hematologic cancer	2.27e-05	0.000293	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NUP214—hematologic cancer	2.26e-05	0.000292	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.24e-05	0.000289	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CALR—hematologic cancer	2.23e-05	0.000288	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—MTR—hematologic cancer	2.22e-05	0.000286	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ABCG2—hematologic cancer	2.22e-05	0.000286	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NQO1—hematologic cancer	2.21e-05	0.000285	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CD44—hematologic cancer	2.21e-05	0.000285	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PARP1—hematologic cancer	2.2e-05	0.000283	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ENO2—hematologic cancer	2.18e-05	0.000281	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.16e-05	0.000279	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FBXW7—hematologic cancer	2.16e-05	0.000279	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HDAC2—hematologic cancer	2.12e-05	0.000273	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CXCR4—hematologic cancer	2.12e-05	0.000273	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTT1—hematologic cancer	2.11e-05	0.000272	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CD44—hematologic cancer	2.09e-05	0.00027	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CYCS—hematologic cancer	2.09e-05	0.00027	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.08e-05	0.000268	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—HSP90AA1—hematologic cancer	2.08e-05	0.000268	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CBL—hematologic cancer	2.06e-05	0.000266	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SDC1—hematologic cancer	2.06e-05	0.000266	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.05e-05	0.000264	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.97e-05	0.000254	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HSP90AA1—hematologic cancer	1.97e-05	0.000254	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.95e-05	0.000251	CbGpPWpGaD
Bromfenac—PTGS2—Disease—STAT1—hematologic cancer	1.9e-05	0.000245	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.87e-05	0.000241	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.86e-05	0.00024	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTP1—hematologic cancer	1.84e-05	0.000238	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.78e-05	0.00023	CbGpPWpGaD
Bromfenac—PTGS2—Disease—GRB2—hematologic cancer	1.78e-05	0.000229	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PDGFA—hematologic cancer	1.77e-05	0.000229	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NQO1—hematologic cancer	1.75e-05	0.000226	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CD44—hematologic cancer	1.75e-05	0.000226	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KITLG—hematologic cancer	1.75e-05	0.000225	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ABCB1—hematologic cancer	1.74e-05	0.000225	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.72e-05	0.000222	CbGpPWpGaD
Bromfenac—PTGS2—Disease—STAT5A—hematologic cancer	1.71e-05	0.00022	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NCOR1—hematologic cancer	1.69e-05	0.000219	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTM1—hematologic cancer	1.69e-05	0.000219	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN2B—hematologic cancer	1.69e-05	0.000218	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYCS—hematologic cancer	1.66e-05	0.000214	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.65e-05	0.000213	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CD86—hematologic cancer	1.64e-05	0.000211	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HES1—hematologic cancer	1.61e-05	0.000208	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NCOR1—hematologic cancer	1.61e-05	0.000207	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGF1—hematologic cancer	1.59e-05	0.000205	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FOXO1—hematologic cancer	1.56e-05	0.000202	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PDGFRB—hematologic cancer	1.56e-05	0.000202	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PDGFRA—hematologic cancer	1.54e-05	0.000198	CbGpPWpGaD
Bromfenac—PTGS2—Disease—JAK1—hematologic cancer	1.53e-05	0.000198	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PRKCG—hematologic cancer	1.53e-05	0.000198	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—MTHFR—hematologic cancer	1.5e-05	0.000193	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.48e-05	0.000192	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTP1—hematologic cancer	1.46e-05	0.000189	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MTHFR—hematologic cancer	1.42e-05	0.000183	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.42e-05	0.000183	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HLA-A—hematologic cancer	1.41e-05	0.000183	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TERT—hematologic cancer	1.41e-05	0.000183	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ABCB1—hematologic cancer	1.38e-05	0.000179	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PDGFB—hematologic cancer	1.38e-05	0.000178	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TSC2—hematologic cancer	1.35e-05	0.000174	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NCOR1—hematologic cancer	1.34e-05	0.000174	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTM1—hematologic cancer	1.34e-05	0.000174	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.32e-05	0.00017	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGFR3—hematologic cancer	1.3e-05	0.000168	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.26e-05	0.000162	CbGpPWpGaD
Bromfenac—PTGS2—Disease—BAD—hematologic cancer	1.23e-05	0.000159	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NOTCH1—hematologic cancer	1.22e-05	0.000157	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CD80—hematologic cancer	1.19e-05	0.000154	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KIT—hematologic cancer	1.19e-05	0.000154	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—MTHFR—hematologic cancer	1.19e-05	0.000153	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PTPN11—hematologic cancer	1.17e-05	0.000151	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CREBBP—hematologic cancer	1.17e-05	0.00015	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CREB1—hematologic cancer	1.13e-05	0.000146	CbGpPWpGaD
Bromfenac—PTGS2—Disease—BRAF—hematologic cancer	1.12e-05	0.000145	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IL6R—hematologic cancer	1.11e-05	0.000143	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.11e-05	0.000143	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CREBBP—hematologic cancer	1.11e-05	0.000143	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ALB—hematologic cancer	1.09e-05	0.000141	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MAP2K1—hematologic cancer	1.05e-05	0.000136	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CD—hematologic cancer	1.05e-05	0.000135	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.05e-05	0.000135	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3R1—hematologic cancer	1.04e-05	0.000135	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGF2—hematologic cancer	1e-05	0.000129	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CG—hematologic cancer	9.98e-06	0.000129	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3R1—hematologic cancer	9.89e-06	0.000128	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CB—hematologic cancer	9.63e-06	0.000124	CbGpPWpGaD
Bromfenac—PTGS2—Disease—JAK2—hematologic cancer	9.62e-06	0.000124	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MDM2—hematologic cancer	9.39e-06	0.000121	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CREBBP—hematologic cancer	9.25e-06	0.000119	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CB—hematologic cancer	9.13e-06	0.000118	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MTOR—hematologic cancer	9.13e-06	0.000118	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CD4—hematologic cancer	9.12e-06	0.000118	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CD—hematologic cancer	8.77e-06	0.000113	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ALB—hematologic cancer	8.66e-06	0.000112	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN1B—hematologic cancer	8.57e-06	0.000111	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTEN—hematologic cancer	8.33e-06	0.000107	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3R1—hematologic cancer	8.29e-06	0.000107	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—EP300—hematologic cancer	7.94e-06	0.000102	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN1A—hematologic cancer	7.91e-06	0.000102	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PTEN—hematologic cancer	7.89e-06	0.000102	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CB—hematologic cancer	7.65e-06	9.87e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—EP300—hematologic cancer	7.53e-06	9.71e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—SRC—hematologic cancer	7.32e-06	9.45e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—STAT3—hematologic cancer	7.06e-06	9.11e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NRAS—hematologic cancer	7.04e-06	9.09e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MAPK3—hematologic cancer	6.74e-06	8.7e-05	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PTEN—hematologic cancer	6.61e-06	8.53e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MYC—hematologic cancer	6.56e-06	8.47e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TGFB1—hematologic cancer	6.54e-06	8.44e-05	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—EP300—hematologic cancer	6.3e-06	8.14e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KRAS—hematologic cancer	6.06e-06	7.82e-05	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CA—hematologic cancer	5.87e-06	7.58e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CA—hematologic cancer	5.57e-06	7.19e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HRAS—hematologic cancer	5.15e-06	6.65e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IL6—hematologic cancer	4.93e-06	6.36e-05	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—AKT1—hematologic cancer	4.8e-06	6.19e-05	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CA—hematologic cancer	4.66e-06	6.02e-05	CbGpPWpGaD
Bromfenac—PTGS2—Disease—AKT1—hematologic cancer	4.55e-06	5.87e-05	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—AKT1—hematologic cancer	3.81e-06	4.92e-05	CbGpPWpGaD
